The United States market has remained flat over the past week, yet it has experienced a notable 21% increase in the last year, with earnings expected to grow by 14% annually. In this context of steady growth and promising forecasts, identifying high-growth tech stocks such as Viant Technology and others can be crucial for investors looking to capitalize on innovation-driven opportunities.
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
Super Micro Computer | 28.91% | 28.19% | ★★★★★★ |
AsiaFIN Holdings | 51.75% | 82.69% | ★★★★★★ |
Ardelyx | 21.09% | 55.29% | ★★★★★★ |
AVITA Medical | 33.20% | 51.87% | ★★★★★★ |
Alkami Technology | 21.99% | 102.65% | ★★★★★★ |
Alnylam Pharmaceuticals | 21.62% | 56.70% | ★★★★★★ |
TG Therapeutics | 29.48% | 45.20% | ★★★★★★ |
Clene | 61.16% | 59.11% | ★★★★★★ |
Travere Therapeutics | 30.95% | 61.73% | ★★★★★★ |
Lumentum Holdings | 21.25% | 118.58% | ★★★★★★ |
Click here to see the full list of 233 stocks from our US High Growth Tech and AI Stocks screener.
Here's a peek at a few of the choices from the screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Viant Technology Inc. is an advertising technology company with a market cap of $1.51 billion.
Operations: Viant Technology generates revenue primarily through its Internet Information Providers segment, which contributed $263.59 million. The company focuses on advertising technology solutions to drive its business operations and financial performance.
Viant Technology, a player in the competitive tech landscape, has shown robust growth with annualized revenue and earnings increases of 11.2% and 30.9%, respectively. This performance is complemented by its strategic alliance with Disney Advertising, enhancing its CTV and digital ad capabilities through advanced AI-driven technologies. Moreover, Viant's commitment to innovation is evident in its R&D spending trends which are crucial for maintaining its competitive edge in the fast-evolving tech sector. These factors collectively underscore Viant's potential to adapt and thrive amidst dynamic market conditions, further evidenced by recent presentations at high-profile conferences that likely bolster investor confidence and market presence.
Evaluate Viant Technology's historical performance by accessing our past performance report.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Endava plc, along with its subsidiaries, offers technology services across North America, Europe, the United Kingdom, and other international regions with a market capitalization of approximately $2.01 billion.
Operations: Endava generates revenue primarily from its computer services segment, amounting to £747.39 million.
Endava stands out with its impressive earnings growth forecast at 41% annually, significantly outpacing the US market average of 14.6%. Despite facing challenges like a substantial one-off loss of £4.7M and a sharp profit margin reduction from 9.5% to 0.9% last year, the company's revenue growth projections remain robust at 9.2% per year, surpassing the US market's expected rate of 8.9%. These figures highlight Endava's resilience and potential for rapid recovery, underscored by its proactive engagement in key industry events such as the upcoming TD Cowen IT Services & Digital Engineering Summit and its Annual General Meeting, which may further shape investor perceptions and strategic direction.
Assess Endava's past performance with our detailed historical performance reports.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: IMAX Corporation, with a market cap of approximately $1.34 billion, operates as a global technology platform for entertainment and events through its subsidiaries.
Operations: IMAX generates revenue primarily through its Technology Products and Services segment, which brought in $214.51 million, followed by Content Solutions at $118.31 million. The company focuses on leveraging its technology platform to enhance entertainment experiences globally.
IMAX, a player in the entertainment technology sector, is navigating a challenging landscape with its earnings growth lagging at -8.3% over the past year compared to the industry average of -3.6%. However, it's not all dim; IMAX's revenue growth is projected at 9.4% annually, outpacing the US market forecast of 8.9%. This growth is underpinned by innovative ventures like the recent announcement of "The Blue Angels" documentary in 3D IMAX format, which could enhance audience engagement and bolster revenue streams. Despite these promising developments, its R&D investments and strategic initiatives will be crucial in maintaining competitive edge and reversing negative earnings trends.
Gain insights into IMAX's past trends and performance with our Past report.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGS:DSP NYSE:DAVA and NYSE:IMAX.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.